全文获取类型
收费全文 | 25712篇 |
免费 | 2371篇 |
国内免费 | 2103篇 |
专业分类
耳鼻咽喉 | 172篇 |
儿科学 | 247篇 |
妇产科学 | 232篇 |
基础医学 | 2993篇 |
口腔科学 | 402篇 |
临床医学 | 3433篇 |
内科学 | 3579篇 |
皮肤病学 | 168篇 |
神经病学 | 1307篇 |
特种医学 | 912篇 |
外国民族医学 | 18篇 |
外科学 | 2944篇 |
综合类 | 4578篇 |
现状与发展 | 4篇 |
一般理论 | 1篇 |
预防医学 | 1788篇 |
眼科学 | 669篇 |
药学 | 2813篇 |
26篇 | |
中国医学 | 1460篇 |
肿瘤学 | 2440篇 |
出版年
2024年 | 96篇 |
2023年 | 386篇 |
2022年 | 962篇 |
2021年 | 1312篇 |
2020年 | 1020篇 |
2019年 | 864篇 |
2018年 | 887篇 |
2017年 | 778篇 |
2016年 | 801篇 |
2015年 | 1170篇 |
2014年 | 1448篇 |
2013年 | 1265篇 |
2012年 | 1763篇 |
2011年 | 2014篇 |
2010年 | 1289篇 |
2009年 | 1038篇 |
2008年 | 1339篇 |
2007年 | 1392篇 |
2006年 | 1302篇 |
2005年 | 1334篇 |
2004年 | 840篇 |
2003年 | 940篇 |
2002年 | 719篇 |
2001年 | 591篇 |
2000年 | 654篇 |
1999年 | 758篇 |
1998年 | 469篇 |
1997年 | 464篇 |
1996年 | 328篇 |
1995年 | 302篇 |
1994年 | 309篇 |
1993年 | 171篇 |
1992年 | 219篇 |
1991年 | 181篇 |
1990年 | 150篇 |
1989年 | 150篇 |
1988年 | 127篇 |
1987年 | 101篇 |
1986年 | 75篇 |
1985年 | 82篇 |
1984年 | 28篇 |
1983年 | 17篇 |
1982年 | 13篇 |
1981年 | 11篇 |
1980年 | 6篇 |
1979年 | 19篇 |
1974年 | 1篇 |
1929年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
2.
Yuxiang Ma Wenfeng Fang Hongyun Zhao Sai Praneeth Bathena Amol Tendolkar Jennifer Sheng Li Zhang 《The oncologist》2021,26(4):e549-e566
Lessons Learned
- The overall safety profiles of ipilimumab 3 mg/kg and 10 mg/kg administered every 3 weeks, were consistent between Chinese patients with solid tumors in the current study and patients from previous U.S. ipilimumab monotherapy studies. No new safety signals were identified.
- The mean systemic exposures to ipilimumab (assessed by first dose area under the curve during the dosing interval and maximum serum concentration) were numerically lower in the Chinese patient population than in U.S. patients for both 3 mg/kg and 10 mg/kg doses; however, the range of serum concentrations in the Chinese and U.S. populations overlapped (3 mg/kg and 10 mg/kg), suggesting that ipilimumab pharmacokinetics was ethnically insensitive in this study.
3.
4.
5.
Jinju Wang Shuzhen Chen Wenfeng Zhang Yanfang Chen Ji C. Bihl 《CNS Neuroscience & Therapeutics》2020,26(12):1255
AimsWe previously showed that the protective effects of endothelial progenitor cells (EPCs)‐released exosomes (EPC‐EXs) on endothelium in diabetes. However, whether EPC‐EXs are protective in diabetic ischemic stroke is unknown. Here, we investigated the effects of EPC‐EXs on diabetic stroke mice and tested whether miR‐126 enriched EPC‐EXs (EPC‐EXsmiR126) have enhanced efficacy.MethodsThe db/db mice subjected to ischemic stroke were intravenously administrated with EPC‐EXs 2 hours after ischemic stroke. The infarct volume, cerebral microvascular density (MVD), cerebral blood flow (CBF), neurological function, angiogenesis and neurogenesis, and levels of cleaved caspase‐3, miR‐126, and VEGFR2 were measured on day 2 and 14.ResultsWe found that (a) injected EPC‐EXs merged with brain endothelial cells, neurons, astrocytes, and microglia in the peri‐infarct area; (b) EPC‐EXsmiR126 were more effective than EPC‐EXs in decreasing infarct size and increasing CBF and MVD, and in promoting angiogenesis and neurogenesis as well as neurological functional recovery; (c) These effects were accompanied with downregulated cleaved caspase‐3 on day 2 and vascular endothelial growth factor receptor 2 (VEGFR2) upregulation till day 14.ConclusionOur results indicate that enrichment of miR126 enhanced the therapeutic efficacy of EPC‐EXs on diabetic ischemic stroke by attenuating acute injury and promoting neurological function recovery. 相似文献
6.
【摘要】 报道临床症状不典型的家族性黑棘皮病1家系。先证者女,4岁,自1周岁时,颈部、腹部出现黑色斑片,近年来逐渐扩大至唇周、躯干前部。腹部皮肤全反式共聚焦显微镜检查可见乳头环下延扭曲及沟壑结构,乳头环内可见中高折光颗粒结构。先证者父亲及祖母既往有类似病史,但随着年龄增长色素沉着自发性消退,仅有局部皮纹增粗。采集先证者及父母、祖母外周血,对先证者外周血DNA行Panel靶向测序,结果显示,先证者存在FGFR3基因14号外显子c.1949A>C(p.Lys650Thr)错义突变,Sanger测序验证证实先证者及其父亲和祖母均存在此突变。诊断:家族性黑棘皮病。 相似文献
7.
8.
9.
10.
Keyang Qian Hanqing Qian Juan Cai Wuheng Yue Xiaoxiao Yu Baorui Liu 《Pathology, research and practice》2019,215(4):755-760
Gastric cancer, one of the most common disease, has become a major public health problem worldwide. Cisplatin (DDP) has been a widely used drug for the treatment of cancer, also usually applied in gastric cancer in clinic. However, the side effects including toxicity and drug-resistance restricted the usage of DDP in clinic, so we prepared a DDP-complexed hydrogel (DDP-Gel) and investigated its efficacy in gastric cancer. For in vivo studies, MKN45-Luc cells were injected into BLAB/C node mice subcutaneously to establish gastric cancer with orthotopically grown tumors. Mice bearing tumors were treated with normal saline, DDP and DDP-Gel. Body weight and survival condition were observed and recorded. The treatment efficacy in vivo was detected by luciferase imaging and histological evaluation was performed by H&E staining of different organs. Additionally, normal ICR mice were treated with different doses of DDP/DDP-Gel to calculate their LD50 in vivo. The results showed that DDP-Gel prolonged survival time and ameliorated body weight changes of mice bearing tumors. DDP-Gel exhibited higher efficacy to inhibit tumor growth and metastasis, compared to DDP. Besides, LD50 of DDP-Gel was 166.0?mg/kg, 13.2 folds higher than DDP. As a conclusion, DDP-Gel showed a more effective and safer function than DDP in gastric cancer, which indicating that DDP-Gel might be a novel strategy for gastric cancer therapy. 相似文献